Patents by Inventor Eric HUMPHRISS

Eric HUMPHRISS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF ADULT GROWTH HORMONE DEFICIENCY WITH HUMAN GROWTH HORMONE ANALOGUES
    Publication number: 20200000884
    Abstract: The present disclosure provides a growth hormone deficiency (GHD) therapy for adult subjects.
    Type: Application
    Filed: July 27, 2017
    Publication date: January 2, 2020
    Inventors: Daniela ROGOFF, Eric HUMPHRISS, Will CHARLTON, Bert BAKKER, Shelby YOUNG
  • TREATMENT WITH HUMAN GROWTH HORMONE ANALOGUES
    Publication number: 20180051063
    Abstract: The present invention concerns an improved therapeutic regimen for GHD therapy. In particular, the invention concerns methods for bolus dose administration of a human growth hormone-XTEN (hGH-XTEN) fusion protein.
    Type: Application
    Filed: July 13, 2017
    Publication date: February 22, 2018
    Inventors: Jeffrey L. Cleland, George M. Bright, Eric Humphriss, Volker Schellenberger, Joshua Silverman, Willem P. Stemmer, Chia-Wei Wang, Nathan Greething, Benjamin Spink
  • TREATMENT OF PEDIATRIC GROWTH HORMONE DEFICIENCY WITH HUMAN GROWTH HORMONE ANALOGUES
    Publication number: 20160158321
    Abstract: The present invention concerns a pediatric growth hormone deficiency (PGHD) therapy for pediatric subjects. The therapy comprises administering to the pediatric patient with PGHD a human growth hormone-XTEN (hGH-XTEN) fusion protein in therapeutically effective doses every week, every two weeks, semimonthly, every three weeks, or monthly. This therapy is not inferior compared to the height velocity achieved with daily injections of hGH not linked to XTEN over the same period.
    Type: Application
    Filed: March 10, 2014
    Publication date: June 9, 2016
    Inventors: Jeffrey L. CLELAND, George M. BRIGHT, Eric HUMPHRISS